Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

NCT01209520 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Non Small Cell Lung Carcinoma
Hypermethylation

Interventions

DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Vidaza
PROCEDURE: Tumor Specimen for Methylation Analysis
PROCEDURE: Blood Sample for Methylation Analysis
DRUG: Vinorelbine
DRUG: Docetaxel
DRUG: Pemetrexed

Sponsor

University of Miami